ClinicalTrials.Veeva

Menu

Cortisol Activity in Patients With Prader-Willi Syndrome and Healthy Controls

Children's Mercy Hospital Kansas City logo

Children's Mercy Hospital Kansas City

Status

Completed

Conditions

Prader-Willi Syndrome

Study type

Observational

Funder types

Other

Identifiers

NCT00932932
09 01-014

Details and patient eligibility

About

The purpose of the study is to find out if people with Prader-Willi syndrome have a difference in the protein which changes inactive cortisone to the active stress hormone cortisol.

Enrollment

36 estimated patients

Sex

All

Ages

6+ months old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Prader-Willi syndrome confirmed by molecular testing, ages 6 months to adult
  • Controls: Age-matched, sex-matched, developmentally normal, BMI-controlled healthy or obese subjects

Exclusion criteria

  • PWS subjects without molecular confirmation of the diagnosis
  • Subjects receiving glucocorticoid treatment within 3 months of evaluation
  • Subjects receiving growth hormone within one year prior to analysis

Trial design

36 participants in 3 patient groups

PWS not receiving Growth Hormone
Control subjects healthy or obese
PWS subjects starting Growth Hormone

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems